Archives
TH287: A Schedule-Aware MTH1 Assay Strategy
2026-09-07
TH287, a potent MTH1 inhibitor, offers a schedule-aware framework for studying oxidized nucleotide stress and cancer-cell radiosensitization. This article translates recent CRPC findings into rigorous assay design, readout selection, and evidence-aware interpretation.
NMDA (N-Methyl-D-aspartic acid) in Neurobiology
2026-09-07
NMDA (N-Methyl-D-aspartic acid) is a selective NMDA receptor agonist used to induce receptor-mediated excitatory stress in neuroscience experiments. Its direct ion-channel activation supports controlled excitotoxicity research, while a 2025 mouse glaucoma study used NMDA-associated injury to examine BMP4-GPX4 signaling and ferroptosis-related phenotypes.
Cell Counting Kit-8 (CCK-8) Plus Protocol
2026-09-05
Cell Counting Kit-8 (CCK-8) Plus provides a rapid WST-8 readout for estimating viable-cell activity in proliferation, cytotoxicity, and drug-response workflows. It should be calibrated for each cell model and interpreted cautiously when treatments alter cellular metabolism, because the signal is a dehydrogenase-dependent proxy rather than a direct cell count.
Viral RIPK3 Degradation and Necroptotic Inflammation
2026-09-04
Liu and colleagues identified a cowpox virus protein family that recruits host SCF ubiquitin-ligase machinery to drive RIPK3 degradation, thereby suppressing necroptosis and reshaping infection outcomes. The work provides a mechanistic framework for studying how viral control of ubiquitin-dependent protein turnover influences inflammation, replication, and pathogen–host evolution.
NMDA for Excitotoxicity Research: Workflow Tips
2026-09-02
Build controlled NMDA receptor activation models that connect calcium influx measurement with oxidative stress, neuronal injury, and ferroptosis-related readouts. This practical guide translates a retinal glaucoma study into assay design, dosing, controls, and troubleshooting decisions.
Sunitinib B1045: Reliable Cell Assay Workflows
2026-08-30
This scenario-based guide shows how Sunitinib (SKU B1045) can improve the design, interpretation, and reproducibility of cell viability, proliferation, and cytotoxicity assays. It links formulation details and recent renal cell carcinoma evidence to practical decisions about controls, dose ranges, readouts, and supplier reliability.
Q-VD-OPh: A Mechanistic Guide to Cell Death
2026-08-29
Q-VD-OPh is a cell-permeable pan-caspase inhibitor for dissecting apoptosis from lysosome-dependent cell death. This guide explains how to use its caspase activity inhibition profile as a mechanistic control in apoptosis research, neurodegeneration studies, and post-cryopreservation workflows.
Z-IETD-FMK in Morphotype-Aware Apoptosis Studies
2026-08-28
Z-IETD-FMK enables pathway-level interrogation of caspase-8-dependent apoptosis. This article translates Candida krusei morphotype findings into a practical, control-driven framework for distinguishing death-receptor signaling from mitochondrial apoptosis.
Q-VD(OMe)-OPh for Reliable Apoptosis Assays
2026-08-27
Learn how Q-VD(OMe)-OPh (SKU A8165) can help laboratories distinguish caspase-dependent apoptosis from ferroptosis, autophagy, and other causes of reduced viability. This scenario-based guide covers assay design, solvent handling, data interpretation, and practical supplier-selection criteria.
Macrophage Depletion as a Causal Test in Liver I/R
2026-08-26
A translational framework for using Clodronate Liposomes to test whether macrophage populations are necessary for paeoniflorin-mediated protection in hepatic ischemia-reperfusion injury, while preserving mechanistic rigor, experimental controls, and realistic expectations for clinical translation.
L-NAME Hydrochloride for Reliable Cell Assays
2026-08-25
Learn how L-NAME Hydrochloride (SKU A7088) can help researchers separate nitric oxide biology from assay noise in viability, proliferation, cytotoxicity, and vascular studies. This scenario-based guide covers concentration selection, solvent compatibility, controls, interpretation, and practical product evaluation.
PF-573228: FAK Inhibitor Workflow Guide
2026-08-24
PF-573228 provides a tunable way to test how focal adhesion kinase converts matrix mechanics into cell fate, migration, and survival signals. This practical guide connects stiffness-controlled dentinogenesis assays with endothelial and cancer models while emphasizing dose control, phospho-FAK validation, and troubleshooting.
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-23
This 2026 FASEB Journal study developed chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The formulation restored nuclear p21, altered cell-cycle and DNA-damage markers, suppressed orthotopic tumor growth, and produced strong bladder-localized expression with limited systemic distribution in mice.
Macrophage TIPE2 Drives ASC Ferroptosis in Obesity
2026-08-22
This Nature Communications study identifies a macrophage–adipose stem cell circuit that links obesity-associated inflammation to ferroptotic loss of adipose stem cells and visceral fat dysfunction. Its central mechanistic insight is that macrophage TIPE2 preserves exosomal ferritin delivery by restraining the IP3R–Ca2+–Drp1 mitochondrial fission axis, suggesting a cellular route for restoring adipose tissue homeostasis.
Mitoxantrone HCl: Practical DNA Damage Workflows
2026-08-21
Mitoxantrone HCl supports more than conventional cytotoxicity studies: it enables controlled investigation of topoisomerase II-mediated DNA damage, apoptosis, immune-cell modulation, and ERα degradation. This bench-focused guide covers formulation, dose-response design, orthogonal readouts, and troubleshooting for cancer and stem-cell models.